John Robinson

Chief Scientific OfficeratCogent Biosciences· In proxies 2022–2025

Pay in FY2025+406% from the year before · Cogent Biosciences stock +355.4% the same year

John Robinson was paid $9.2M in FY2025 (Dec), up 406%. Cogent Biosciences stock rose 355.4% that year.

Pay$100 in the stock at the end of FY21 → $414

Pay is from the Summary Compensation Table of each Cogent Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

COGT
Cogent BiosciencesPublic company · 4 yr
- Chief Scientific Officer2022 – Present · 4 yrStock in role +287%

Roles come from the proxy statements of each company.

Activity

Pay
Cogent Biosciences Chief Scientific Officer pay rose 406% to $9.2M. The stock rose 355% in FY2025 (Dec).
DEF 14AApr 23, 2026
Pay
Cogent Biosciences Chief Scientific Officer pay fell 39% to $1.8M. The stock rose 33% in FY2024 (Dec).
DEF 14AApr 22, 2025
Pay
Cogent Biosciences Chief Scientific Officer pay rose 59% to $3.0M. The stock fell 49% in FY2023 (Dec).
DEF 14AApr 23, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?